{"id":403728,"date":"2025-07-15T13:30:00","date_gmt":"2025-07-15T11:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/glp-1ra-in-mash-whats-new\/"},"modified":"2025-07-15T15:08:23","modified_gmt":"2025-07-15T13:08:23","slug":"glp-1ra-in-mash-whats-new","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/glp-1ra-in-mash-whats-new\/","title":{"rendered":"GLP-1RA in MASH &#8211; what&#8217;s new?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Metabolic dysfunction-associated steatohepatitis (MASH) corresponds to<br \/>the liver disease formerly known as non-alcoholic fatty liver inflammation (NASH). The most common causes of MASH are obesity and diabetes. There are still no specifically approved drugs in this country, which is why pharmacotherapy focuses on the accompanying metabolic diseases. The GLP-1RA semaglutide can contribute to a reduction in fibrosis in MASH, as current study findings show. Interesting data are also available on resmetirome and other active substances.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fglp-1ra-in-mash-whats-new%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Metabolic dysfunction-associated steatohepatitis (MASH) corresponds tothe liver disease formerly known as non-alcoholic fatty liver inflammation (NASH). The most common causes of MASH are obesity and diabetes. There are still no&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fglp-1ra-in-mash-whats-new%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":403731,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Steatotic liver disease  ","footnotes":""},"category":[11513,11384,11391,11297,11442,11548,11503],"tags":[83699,83696,83694,83697,46410,83695,17444],"powerkit_post_featured":[],"class_list":["post-403728","post","type-post","status-publish","format-standard","has-post-thumbnail","category-congress-reports","category-endocrinology-and-diabetology","category-gastroenterology-and-hepatology","category-general-internal-medicine","category-pharmacology-and-toxicology","category-rx-en","category-studies","tag-fibrosis-reduction","tag-glp-1ra-en","tag-mash-en-3","tag-metabolic-dysfunction-associated-steatohepatitis","tag-nash-en","tag-non-alcoholic-fatty-liver-inflammation","tag-semaglutide-en-2","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-16 10:36:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":403730,"slug":"glp-1ra-pour-mash-quoi-de-neuf","post_title":"GLP-1RA pour MASH - quoi de neuf ?","href":"https:\/\/medizinonline.com\/fr\/glp-1ra-pour-mash-quoi-de-neuf\/"},"it_IT":{"locale":"it_IT","id":403734,"slug":"glp-1ra-nella-mash-quali-sono-le-novita","post_title":"GLP-1RA nella MASH - quali sono le novit\u00e0?","href":"https:\/\/medizinonline.com\/it\/glp-1ra-nella-mash-quali-sono-le-novita\/"},"pt_PT":{"locale":"pt_PT","id":403732,"slug":"glp-1ra-em-mash-o-que-ha-de-novo","post_title":"GLP-1RA em MASH - o que h\u00e1 de novo?","href":"https:\/\/medizinonline.com\/pt-pt\/glp-1ra-em-mash-o-que-ha-de-novo\/"},"es_ES":{"locale":"es_ES","id":403735,"slug":"glp-1ra-en-el-mash-que-hay-de-nuevo","post_title":"GLP-1RA en el MASH: \u00bfqu\u00e9 hay de nuevo?","href":"https:\/\/medizinonline.com\/es\/glp-1ra-en-el-mash-que-hay-de-nuevo\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/403728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=403728"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/403728\/revisions"}],"predecessor-version":[{"id":405154,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/403728\/revisions\/405154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/403731"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=403728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=403728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=403728"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=403728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}